FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
Abroad (travel likely)Recruiting
Conditions
Fibroblast Growth Factor 23 · Anemia · CKD
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital Universitario Reina Sofia, Córdoba, Spain
Contact: Study coordinator (Casimiro Valle Dominguez, MD) · casimiro.valle.sspa@juntadeandalucia.es · 34 957010000
Study leads
Juan Muñoz Castañeda, MD
Principal Investigator
Maimónides Biomedical Research Institute of Córdoba